BSE filing, NSE: JDORGOCHEM. Summary written from the filing by ALFA Finder's alert engine.
Jaysynth Orgochem Ltd: key numbers
- Share price
- ₹13.30
- Market cap
- ₹179.4 Cr
- Revenue (annual)
- ₹259.7 Cr
- Net profit (annual)
- ₹14.66 Cr
- P/E (TTM)
- 9.7×Sector 34.1×
- Promoter holding
- 73.68%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jaysynth Orgochem Ltd
All →Jaysynth Orgochem Other Announcement
Jaysynth Orgochem Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Jaysynth Orgochem Management Change
Jaysynth Orgochem Limited has appointed M/s. Chhogmal & Co. as its Statutory Auditor for a term of 60 months effective September 28, 2026.
Jaysynth Orgochem Other Announcement
Jaysynth Orgochem Limited has appointed M/s. Chhogmal & Co. as its Statutory Auditor for a five-year term, following approval at the 52nd Annual General Meeting.
Jaysynth Orgochem Annual General Meeting
Jaysynth Orgochem Limited held its 52nd Annual General Meeting on September 28, 2026, where shareholders transacted ordinary and special business, including dividend declarations.
Jaysynth Orgochem Other Announcement
Jaysynth Orgochem Limited shared the web link for its 52nd AGM notice and Annual Report for FY 2025-26 with unregistered shareholders as required by regulation.
Jaysynth Orgochem Annual General Meeting
Jaysynth Orgochem Limited has issued the notice for its 52nd Annual General Meeting, scheduled for September 28, 2026. The meeting will address financial statements and dividend declarations.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr